Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Schäfers

Showing results (1-10 of 313) with videos related to

Pageof 32
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|September 30, 2010
PET, CT and MRI characterisation of the atherosclerotic plaqueGiovanni Lucignani, Michael Schäfers
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|May 18, 2026
Preclinical PET, PET/CT, and PET/MRISonja Schelhaas, Michael Schäfers
Future Medicinal Chemistry|July 2, 2015
Isatin sulfonamides: potent caspases-3 and -7 inhibitors, and promising PET and SPECT radiotracers for apoptosis imagingPanupun Limpachayaporn, Michael Schäfers, Günter Haufe
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 5, 2010
Matrix-metalloproteinases as imaging targets for inflammatory activity in atherosclerotic plaquesMichael Schäfers, Otmar Schober, Sven Hermann
Nuclear Medicine and Biology|September 13, 2016
Radioligand therapy with <sup>177</sup>Lu-PSMA-617 of metastatic prostate cancer has already been arrived in clinical useHojjat Ahmadzadehfar, Markus Essler, Michael Schäfers, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 15, 2008
EANM-ESR white paper on multimodality imagingLars Stegger, Michael Schäfers, Matthias Weckesser, et al.
Contrast Media & Molecular Imaging|October 31, 2012
Performance of a new fluorescence-labeled MMP inhibitor to image tumor MMP activity in vivo in comparison to an MMP-activatable probeBianca Waschkau, Andreas Faust, Michael Schäfers, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 2, 2023
Infection Imaging: Focus on New Tracers?Wolfgang Roll, Andreas Faust, Sven Hermann, et al.
Journal of Materials Chemistry. B|April 9, 2020
A combined experimental and computational study of the substituent effect on the photodynamic efficacy of amphiphilic Zn(ii)phthalocyaninesAnzhela Galstyan, Kristina Riehemann, Michael Schäfers, et al.
Bioconjugate Chemistry|May 7, 2013
Design and synthesis of small-molecule fluorescent photoprobes targeted to aminopeptdase N (APN/CD13) for optical imaging of angiogenesisAnke Hahnenkamp, Michael Schäfers, Christoph Bremer, et al.
Pageof 32

Showing results (1-10 of 313) with videos related to

Sort By:
Pageof 32
European Journal of Nuclear Medicine and Molecular Imaging|September 30, 2010
PET, CT and MRI characterisation of the atherosclerotic plaqueGiovanni Lucignani, Michael Schäfers
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|May 18, 2026
Preclinical PET, PET/CT, and PET/MRISonja Schelhaas, Michael Schäfers
Future Medicinal Chemistry|July 2, 2015
Isatin sulfonamides: potent caspases-3 and -7 inhibitors, and promising PET and SPECT radiotracers for apoptosis imagingPanupun Limpachayaporn, Michael Schäfers, Günter Haufe
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 5, 2010
Matrix-metalloproteinases as imaging targets for inflammatory activity in atherosclerotic plaquesMichael Schäfers, Otmar Schober, Sven Hermann
Nuclear Medicine and Biology|September 13, 2016
Radioligand therapy with <sup>177</sup>Lu-PSMA-617 of metastatic prostate cancer has already been arrived in clinical useHojjat Ahmadzadehfar, Markus Essler, Michael Schäfers, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 15, 2008
EANM-ESR white paper on multimodality imagingLars Stegger, Michael Schäfers, Matthias Weckesser, et al.
Contrast Media & Molecular Imaging|October 31, 2012
Performance of a new fluorescence-labeled MMP inhibitor to image tumor MMP activity in vivo in comparison to an MMP-activatable probeBianca Waschkau, Andreas Faust, Michael Schäfers, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 2, 2023
Infection Imaging: Focus on New Tracers?Wolfgang Roll, Andreas Faust, Sven Hermann, et al.
Journal of Materials Chemistry. B|April 9, 2020
A combined experimental and computational study of the substituent effect on the photodynamic efficacy of amphiphilic Zn(ii)phthalocyaninesAnzhela Galstyan, Kristina Riehemann, Michael Schäfers, et al.
Bioconjugate Chemistry|May 7, 2013
Design and synthesis of small-molecule fluorescent photoprobes targeted to aminopeptdase N (APN/CD13) for optical imaging of angiogenesisAnke Hahnenkamp, Michael Schäfers, Christoph Bremer, et al.
Pageof 32